Lowe, John B.
Genentech, Inc,
United States
2024 Rank: 125391
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Immunology
Rank in SubField 1: 2190 out of 208384 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 125391 | 139158 |
| Total Cites | 513 | 536 |
| H-index | 9 | 9 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 19 | 19 |
| Total Cites to Single Authored Papers | 15 | 15 |
| Number of Single+First Authored Papers | 42 | 42 |
| Total Cites to Single+First Authored Papers | 37 | 40 |
| Number of Single+First+Last Authored Papers | 89 | 89 |
| Total Cites to Single+First+Last Authored Papers | 192 | 195 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 455 | 473 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.13 |
| Self-Citation Percentage |
4.29%
|
|
Lowe, John B.
Genentech, Inc,
United States
2023 Rank: 99056
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Immunology
Rank in SubField 1: 1980 out of 204091 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 99056 | 112942 |
| Total Cites | 533 | 560 |
| H-index | 9 | 9 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 19 | 19 |
| Total Cites to Single Authored Papers | 22 | 22 |
| Number of Single+First Authored Papers | 42 | 42 |
| Total Cites to Single+First Authored Papers | 46 | 47 |
| Number of Single+First+Last Authored Papers | 89 | 89 |
| Total Cites to Single+First+Last Authored Papers | 201 | 204 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 477 | 497 |
| Ratio of Total Citations to Distinct Citing Papers | 1.12 | 1.13 |
| Self-Citation Percentage |
4.82%
|
|
Lowe, John B.
Genentech Incorporated,
United States
2022 Rank: 70800
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Immunology
Rank in SubField 1: 1668 out of 201173 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 70800 | 81269 |
| Total Cites | 599 | 639 |
| H-index | 11 | 11 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 19 | 19 |
| Total Cites to Single Authored Papers | 20 | 20 |
| Number of Single+First Authored Papers | 42 | 42 |
| Total Cites to Single+First Authored Papers | 47 | 47 |
| Number of Single+First+Last Authored Papers | 89 | 89 |
| Total Cites to Single+First+Last Authored Papers | 235 | 239 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 516 | 542 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.18 |
| Self-Citation Percentage |
6.26%
|
|
Lowe, John B.
Genentech Incorporated,
United States
2021 Rank: 81508
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Immunology
Rank in SubField 1: 1835 out of 189264 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 81508 | 89194 |
| Total Cites | 806 | 862 |
| H-index | 12 | 13 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 19 | 19 |
| Total Cites to Single Authored Papers | 25 | 25 |
| Number of Single+First Authored Papers | 42 | 42 |
| Total Cites to Single+First Authored Papers | 70 | 70 |
| Number of Single+First+Last Authored Papers | 89 | 89 |
| Total Cites to Single+First+Last Authored Papers | 328 | 334 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 708 | 753 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.14 |
| Self-Citation Percentage |
6.50%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.